InsiderTrades

Form 4 for PRTA PROTHENA CORP PUBLIC LTD CO

Accepted 2022-11-09 00:00:00 ET · period of report 2022-11-07 · accession 0001567619-22-019408 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-11-09 2022-11-07 PRTA COLLIER RICHARD T Dir S - Sale+OE $55.62 -5,000 1,219 -80% -$278.1K
D 2022-11-09 2022-11-07 PRTA COLLIER RICHARD T Dir M - OptEx $6.41 +5,000 6,219 +410% +$32.0K
D 2022-11-09 2022-11-07 PRTA COLLIER RICHARD T Dir M - OptEx $0.00 -5,000 10.0K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares, par value $0.01 per share 2022-11-07 S D 1,486 $54.74 4,733 D — — (F2) The transaction was executed in multiple trades in prices ranging from $54.29 to $55.195, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 4 of this Form 4.
2 Common Ordinary Shares, par value $0.01 per share 2022-11-07 S D 2,688 $55.71 2,045 D — — (F3) The transaction was executed in multiple trades in prices ranging from $55.29 to $56.27, inclusive.
3 Common Ordinary Shares, par value $0.01 per share 2022-11-07 S D 826 $56.89 1,219 D — — (F4) The transaction was executed in multiple trades in prices ranging from $56.37 to $57.23, inclusive.
4 Common Ordinary Shares, par value $0.01 per share 2022-11-07 M A 5,000 $6.41 6,219 D — —
5 Derivative Stock Option (Right to Buy) 2022-11-07 M D 5,000 $0.00 10,000 D $6.41 · 2014-01-29 to 2023-01-29 5,000 Ordinary Shares (F5) The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately three months and be forfeited to the extent it is not exercised on or prior to January 29, 2023.